ArticleCancer chemotherapy and pharmacology2017

Superactive human leptin antagonist (SHLA), triple Lan1 and quadruple Lan2 leptin mutein as a promising treatment for human folliculoma.

E Fiedor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.